209 related articles for article (PubMed ID: 22517167)
1. Physicochemical characterization and structural evaluation of a specific 2:1 cocrystal of naproxen-nicotinamide.
Ando S; Kikuchi J; Fujimura Y; Ida Y; Higashi K; Moribe K; Yamamoto K
J Pharm Sci; 2012 Sep; 101(9):3214-21. PubMed ID: 22517167
[TBL] [Abstract][Full Text] [Related]
2. Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization.
Basavoju S; Boström D; Velaga SP
Pharm Res; 2008 Mar; 25(3):530-41. PubMed ID: 17703346
[TBL] [Abstract][Full Text] [Related]
3. Identifying the intermolecular hydrogen-bonding supramolecular synthons in an indomethacin-nicotinamide cocrystal by solid-state NMR.
Maruyoshi K; Iuga D; Antzutkin ON; Alhalaweh A; Velaga SP; Brown SP
Chem Commun (Camb); 2012 Nov; 48(88):10844-6. PubMed ID: 23023334
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism in sulfadimidine/4-aminosalicylic acid cocrystals: solid-state characterization and physicochemical properties.
Grossjohann C; Serrano DR; Paluch KJ; O'Connell P; Vella-Zarb L; Manesiotis P; Mccabe T; Tajber L; Corrigan OI; Healy AM
J Pharm Sci; 2015 Apr; 104(4):1385-98. PubMed ID: 25605031
[TBL] [Abstract][Full Text] [Related]
5. Crystallization pathways and kinetics of carbamazepine-nicotinamide cocrystals from the amorphous state by in situ thermomicroscopy, spectroscopy, and calorimetry studies.
Seefeldt K; Miller J; Alvarez-Núñez F; Rodríguez-Hornedo N
J Pharm Sci; 2007 May; 96(5):1147-58. PubMed ID: 17455346
[TBL] [Abstract][Full Text] [Related]
6. Preparation, structural analysis, and properties of tenoxicam cocrystals.
Patel JR; Carlton RA; Needham TE; Chichester CO; Vogt FG
Int J Pharm; 2012 Oct; 436(1-2):685-706. PubMed ID: 22841852
[TBL] [Abstract][Full Text] [Related]
7. Initial dissolution kinetics of cocrystal of carbamazepine with nicotinamide.
Hattori Y; Sato M; Otsuka M
J Pharm Pharmacol; 2015 Nov; 67(11):1512-8. PubMed ID: 26285918
[TBL] [Abstract][Full Text] [Related]
8. A novel strategy for pharmaceutical cocrystal generation without knowledge of stoichiometric ratio: myricetin cocrystals and a ternary phase diagram.
Hong C; Xie Y; Yao Y; Li G; Yuan X; Shen H
Pharm Res; 2015 Jan; 32(1):47-60. PubMed ID: 24939640
[TBL] [Abstract][Full Text] [Related]
9. HPLC determination of olanzapine and carbamazepine in their nicotinamide cocrystals and investigation of the dissolution profiles of cocrystal tablet formulations.
Renkoğlu P; Çelebier M; Arıca-Yegin B
Pharm Dev Technol; 2015 May; 20(3):380-4. PubMed ID: 24521464
[TBL] [Abstract][Full Text] [Related]
10. Monitoring ibuprofen-nicotinamide cocrystal formation during solvent free continuous cocrystallization (SFCC) using near infrared spectroscopy as a PAT tool.
Kelly AL; Gough T; Dhumal RS; Halsey SA; Paradkar A
Int J Pharm; 2012 Apr; 426(1-2):15-20. PubMed ID: 22274588
[TBL] [Abstract][Full Text] [Related]
11. Theophylline-nicotinamide cocrystal formation in physical mixture during storage.
Ervasti T; Aaltonen J; Ketolainen J
Int J Pharm; 2015; 486(1-2):121-30. PubMed ID: 25800677
[TBL] [Abstract][Full Text] [Related]
12. Improving the solubility of dexlansoprazole by cocrystallization with isonicotinamide.
Li J; Wang L; Ye YQ; Fu X; Ren Q; Zhang H; Deng Z
Eur J Pharm Sci; 2016 Mar; 85():47-52. PubMed ID: 26836368
[TBL] [Abstract][Full Text] [Related]
13. The cocrystal nicotinamide-succinic acid (2/1).
Thompson LJ; Voguri RS; Cowell A; Male L; Tremayne M
Acta Crystallogr C; 2010 Aug; 66(Pt 8):o421-4. PubMed ID: 20679721
[TBL] [Abstract][Full Text] [Related]
14. Terahertz spectroscopy and computational investigation of the flufenamic acid/nicotinamide cocrystal.
Delaney SP; Korter TM
J Phys Chem A; 2015 Apr; 119(13):3269-76. PubMed ID: 25787318
[TBL] [Abstract][Full Text] [Related]
15. A 1:1 cocrystal of baicalein with nicotinamide.
Sowa M; Ślepokura K; Matczak-Jon E
Acta Crystallogr C; 2012 Jul; 68(Pt 7):o262-5. PubMed ID: 22763693
[TBL] [Abstract][Full Text] [Related]
16. Predicting the Solubility of Pharmaceutical Cocrystals in Solvent/Anti-Solvent Mixtures.
Lange L; Heisel S; Sadowski G
Molecules; 2016 May; 21(5):. PubMed ID: 27164075
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of electrospray deposition for rapid screening of the cocrystal formation and single step, continuous production of pharmaceutical nanococrystals.
Emami S; Siahi-Shadbad M; Barzegar-Jalali M; Adibkia K
Drug Dev Ind Pharm; 2018 Jun; 44(6):1034-1047. PubMed ID: 29347850
[TBL] [Abstract][Full Text] [Related]
18. A New Ferulic Acid-Nicotinamide Cocrystal With Improved Solubility and Dissolution Performance.
Chaves Júnior JV; Dos Santos JAB; Lins TB; de Araújo Batista RS; de Lima Neto SA; de Santana Oliveira A; Nogueira FHA; Gomes APB; de Sousa DP; de Souza FS; Aragão CFS
J Pharm Sci; 2020 Mar; 109(3):1330-1337. PubMed ID: 31821823
[TBL] [Abstract][Full Text] [Related]
19. Characterisation, solubility and intrinsic dissolution behaviour of benzamide: dibenzyl sulfoxide cocrystal.
Grossjohann C; Eccles KS; Maguire AR; Lawrence SE; Tajber L; Corrigan OI; Healy AM
Int J Pharm; 2012 Jan; 422(1-2):24-32. PubMed ID: 22020274
[TBL] [Abstract][Full Text] [Related]
20. Cocrystal formulations: A case study of topical formulations consisting of ferulic acid cocrystals.
Aitipamula S; Das S
Eur J Pharm Biopharm; 2020 Apr; 149():95-104. PubMed ID: 32035236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
